-  - Zm. - Wolumen Bid- Ask- Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
-EUR - -
Obrót: -
-Wolumen Bid: - -Wolumen Ask: - 2,95 mldEUR - -

Opis działalności

Tecan Group AG is one of the leading global providers of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also one of the leaders in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.
 

Zarząd & Rada nadzorcza

CEO
Dr. Achim von Leoprechting
Zarząd
Tania Micki, Andreas Wilhelm, Dr. Wael Yared, Erik Norström, Ingrid Pürgstaller, Ralf Griebel, Ulrich Kanter, Mukta Acharya
Rada nadzorcza
Dr. Lukas Braunschweiler, Dr. Christa Kreuzburg, Dr. Daniel R. Marshak, Dr. Karen J. Huebscher, Dr. Oliver S. Fetzer, Myra Eskes, Matthias Gillner, Monica Manotas
 

Dane firmy

Nazwa: Tecan Group AG
Adres: Seestrasse 103,CH-8708 Männedorf
Telefon: +41-44-922-8111
Fax: +41-44-922-8112
E-mail: info@tecan.com
Internet: www.tecan.com
Przemysł: Służba zdrowia
Sektor: Produkty Medyczne
Podsektor: Zaawansowane Urządzenia Medyczne
Koniec roku finansowego: 31.12
Free float: 61,50%
Data IPO: -

Relacje inwestorskie

Nazwa: Martin Brändle
Telefon: +41-44-922-8430
Fax: +41-44-922-8889
E-mail: investor@tecan.com

Główni akcjonariusze

Inne
 
55,70%
Chase Nominees Ltd.
 
12,20%
UBS Fund Management AG
 
5,10%
APG Algemene Pensioen Groep N.V
 
4,50%
BlackRock Inc.
 
4,50%
FIL Limited, Pembroke
 
3,00%
Candriam Luxembourg
 
3,00%
Swisscanto Fondsleitung AG
 
3,00%
Credit Suisse Funds AG
 
3,00%
Inne
 
6,00%